Crowdsourcing the Diagnosis of Incurable Diseases Through AI

We are now quite used to seeing the disruption that’s taking place in many marketplaces due to the combination of new technology and mass connectivity in the hands of visionary startups, unencumbered by the ‘rules’ of established business models. Though how about when a global corporation is bold enough to disrupt itself? This is what some think the Philip Morris International (PMI) tobacco company did when it set out to create a smoke-free future through the development of Reduced Risk Products (RRPs). And the organization they founded to do this now brings together scientists from all over the world to address some of humanity’s greatest challenges, including irritable bowel disease.

As part of their process to develop smoke-free products in a way that would be robust enough to withstand intense scientific scrutiny, PMI launched sbv IMPROVER as an industry initiative to harness the wisdom of the crowd in global science. The purpose was to provide a measure of quality control through gaining external third-party validation of the methodologies used. sbv IMPROVER stands for Systems Biology Verification combined with Industrial Methodology for Process Verification in Research.

Source: World IBD Day
Schematic representation of the challenge and its two sub-challenges. Image source: sbv IMPROVER

A global stage for innovators to present collaborative solutions for the 21st century | Seeking guest contributors with something to say about the crowd economy